Brief: Zevra Therapeutics Reports Q2 Results

Zevra Therapeutics

14/08/2023 12:34

Aug 14 (Reuters) - Zevra Therapeutics Inc  ZVRA.O :
    * ZEVRA THERAPEUTICS REPORTS CORPORATE UPDATES AND SECOND
QUARTER
2023 FINANCIAL RESULTS
    * ZEVRA THERAPEUTICS INC Q2 LOSS PER SHARE $0.15
    * ZEVRA THERAPEUTICS INC Q2 REVENUE $8.5 MILLION VERSUS $1.3
MILLION
    * ZEVRA THERAPEUTICS INC - ENDED Q2 2023 WITH $87.4 MILLION
IN
CASH, CASH EQUIVALENTS, AND INVESTMENTS, SUPPORTING OUR
FORECASTED CASH RUNWAY INTO 2026
    * ZEVRA THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.15

Source text for Eikon:  ID:nGNX9fDxKD 
Further company coverage:  ZVRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))